Literature DB >> 29582894

Sex Differences in the Associations between L-Arginine Pathway Metabolites, Skeletal Muscle Mass and Function, and their Responses to Resistance Exercise, in Old Age.

M Da Boit1, S Tommasi, D Elliot, A Zinellu, S Sotgia, R Sibson, J R Meakin, R M Aspden, C Carru, A A Mangoni, S R Gray.   

Abstract

OBJECTIVES: The current study was designed to explore the associations between L-arginine metabolites and muscle mass and function in old age, which are largely unknown.
DESIGN: The study used a randomised, double-blind, placebo-controlled design.
SETTING: The study was carried out in a laboratory setting. PARTICIPANTS: 50 healthy older adults [median age 70 years (IQR 67-73); 27 males]. INTERVENTION: Participants undertook an 18-week resistance exercise program, and a nutritional intervention (fish oil vs. placebo). MEASUREMENTS: Serum homoarginine, ornithine, citrulline, asymmetric dimethylarginine (ADMA), NG-monomethyl-L-arginine (L-NMMA), and symmetric dimethylarginine (SDMA), maximal voluntary contraction (MVC) and isokinetic torque of the knee extensors at 30° s-1 (MIT), muscle cross sectional area (MCSA) and quality (MQ) were measured at baseline and after the intervention.
RESULTS: No significant exercise-induced changes were observed in metabolite concentrations. There were significant sex differences in the associations between metabolites and muscle parameters. After adjusting for age, glomerular filtration rate and fish oil intervention, citrulline (P=0.002) and ornithine (P=0.022) were negatively associated with MCSA at baseline in males but not females. However, baseline citrulline was negatively correlated with exercise-induced changes in MVC (P=0.043) and MQ (P=0.026) amongst females. Furthermore, amongst males, baseline homoarginine was positively associated with exercise-induced changes in MVC (P=0.026), ADMA was negatively associated with changes in MIT (P=0.026), L-NMMA (p=0.048) and ornithine (P<0.001) were both positively associated with changes in MCSA, and ornithine was negatively associated with changes in MQ (P=0.039).
CONCLUSION: Therefore, barring citrulline, there are significant sex differences in the associations between L-arginine metabolites and muscle mass and function in healthy older adults. These metabolites might enhance sarcopenia risk stratification, and the success of exercise programs, in old age.

Entities:  

Keywords:  L-arginine metabolites; exercise; muscle function; muscle mass; old age

Mesh:

Substances:

Year:  2018        PMID: 29582894     DOI: 10.1007/s12603-017-0964-6

Source DB:  PubMed          Journal:  J Nutr Health Aging        ISSN: 1279-7707            Impact factor:   4.075


  29 in total

Review 1.  Comparative properties of arginases.

Authors:  C P Jenkinson; W W Grody; S D Cederbaum
Journal:  Comp Biochem Physiol B Biochem Mol Biol       Date:  1996-05       Impact factor: 2.231

2.  Estradiol augments while progesterone inhibits arginine transport in human endothelial cells through modulation of cationic amino acid transporter-1.

Authors:  Ohad S Bentur; Doron Schwartz; Tamara Chernichovski; Merav Ingbir; Talia Weinstein; Gil Chernin; Idit F Schwartz
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2015-06-10       Impact factor: 3.619

3.  Associations of homoarginine with bone metabolism and density, muscle strength and mortality: cross-sectional and prospective data from 506 female nursing home patients.

Authors:  S Pilz; A Meinitzer; A Tomaschitz; K Kienreich; H Dobnig; M Schwarz; D Wagner; C Drechsler; C Piswanger-Sölkner; W März; A Fahrleitner-Pammer
Journal:  Osteoporos Int       Date:  2012-03-17       Impact factor: 4.507

Review 4.  Age-related and disease-related muscle loss: the effect of diabetes, obesity, and other diseases.

Authors:  Rita Rastogi Kalyani; Mark Corriere; Luigi Ferrucci
Journal:  Lancet Diabetes Endocrinol       Date:  2014-03-06       Impact factor: 32.069

Review 5.  Nitric oxide as a challenge for the clinical chemistry laboratory.

Authors:  L Viinikka
Journal:  Scand J Clin Lab Invest       Date:  1996-11       Impact factor: 1.713

6.  The healthcare costs of sarcopenia in the United States.

Authors:  Ian Janssen; Donald S Shepard; Peter T Katzmarzyk; Ronenn Roubenoff
Journal:  J Am Geriatr Soc       Date:  2004-01       Impact factor: 5.562

7.  Incidence of and risk factors for falls and injurious falls among the community-dwelling elderly.

Authors:  J L O'Loughlin; Y Robitaille; J F Boivin; S Suissa
Journal:  Am J Epidemiol       Date:  1993-02-01       Impact factor: 4.897

8.  Association of Serum Asymmetric Dimethylarginine With Muscle Strength and Gait Speed: A Cross-Sectional Study of the HEIJO-KYO Cohort.

Authors:  Kenji Obayashi; Keigo Saeki; Taeko Maegawa; Takahide Sakai; Maiko Kitagawa; Naoto Otaki; Hiroshi Kataoka; Norio Kurumatani
Journal:  J Bone Miner Res       Date:  2016-01-20       Impact factor: 6.741

9.  Substrate specificity of NO synthases: detailed comparison of L-arginine, homo-L-arginine, their N omega-hydroxy derivatives, and N omega-hydroxynor-L-arginine.

Authors:  C Moali; J L Boucher; M A Sari; D J Stuehr; D Mansuy
Journal:  Biochemistry       Date:  1998-07-21       Impact factor: 3.162

10.  Transsulfuration pathway thiols and methylated arginines: the Hunter Community Study.

Authors:  Arduino A Mangoni; Angelo Zinellu; Ciriaco Carru; John R Attia; Mark McEvoy
Journal:  PLoS One       Date:  2013-01-24       Impact factor: 3.240

View more
  2 in total

1.  Arginase II Plays a Central Role in the Sexual Dimorphism of Arginine Metabolism in C57BL/6 Mice.

Authors:  Mahmoud A Mohammad; Inka C Didelija; Juan C Marini
Journal:  J Nutr       Date:  2020-12-10       Impact factor: 4.798

2.  Impact of a High Protein Intake on the Plasma Metabolome in Elderly Males: 10 Week Randomized Dietary Intervention.

Authors:  Brenan Durainayagam; Cameron J Mitchell; Amber M Milan; Nina Zeng; Pankaja Sharma; Sarah M Mitchell; Farha Ramzan; Scott O Knowles; Anders Sjödin; Karl-Heinz Wagner; Nicole C Roy; Karl Fraser; David Cameron-Smith
Journal:  Front Nutr       Date:  2019-12-06
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.